Science Advances-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=883760, encodeId=5c5c883e6091, content= 投SCIENCE TRANSLATIONAL MEDICINE被拒，建议转投此杂志，不知机会大不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=497, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211006/298c300ad56d42b6a130908b27e6c26d/fc5b8fd50ac144f3973fdc4b334d8e25.jpg, createdBy=2bb42569605, createdName=你好，阿蒙, createdTime=Wed Sep 09 01:21:16 CST 2020, time=2020-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861823, encodeId=7f2786182372, content=审稿速度:4.0 经验分享：20200127 投稿 20200327 第一轮修改，三个审稿人（两个小修，一个大修） 20200505 第一轮修改，三个审稿人（两个同意接收，一个小修） 20200528 accept-technical hold 20200602 付版面费 4500 usd 20200612 accepted 希望对投稿的人有所帮助！！！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=590, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdbe5414035, createdName=ms3036779279854874, createdTime=Sat Jun 13 11:06:00 CST 2020, time=2020-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861406, encodeId=fb7f86140618, content=审稿速度:1.0 经验分享：大佬们的游戏而已，注定没法和pnas和子刊比 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=513, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e295414102, createdName=ms4512939187244456, createdTime=Thu Jun 04 09:47:58 CST 2020, time=2020-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860949, encodeId=41128609490c, content=审稿速度:1.0 经验分享：2019.05.24 transferred , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=465, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a595414065, createdName=ms6437770273944149, createdTime=Mon May 25 10:23:32 CST 2020, time=2020-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887481, encodeId=c72288e481a8, content=审稿速度:2.0 经验分享：课题被抢发到了JCI, 我们投立刻JCI被拒绝，19年9月投稿，12月接收，20年2月见刊。期间三个审稿人给了非常专业的问题，一一认真回答后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=328, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6811738319, createdName=James SUN, createdTime=Tue Sep 22 21:20:47 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125857, encodeId=992a212585e5b, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：等待煎熬中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9578600405, createdName=ms4000001399579030, createdTime=Fri Apr 14 10:26:25 CST 2023, time=2023-04-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=978565, encodeId=6b889e856566, content=偏重的研究方向：生物化学 经验分享：投稿到拒稿只用了4天，快乐！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1b35512140, createdName=大药, createdTime=Thu Jul 01 11:07:35 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601337, encodeId=ba1260133e43, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：这个杂志真不靠谱，投稿两个多月，换了几个编辑，最后没送审直接拒了。效率极低，耽误时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=423, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3ztLHSarrwfOxbw2WGK8AvWRfUlNGpox5ZAd4d306Fyt8IJ74jVsx5AFKXzgmazgF44vyNm25iaF8A/0, createdBy=2e152100215, createdName=jurryz, createdTime=Thu Jun 04 10:45:49 CST 2020, time=2020-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859385, encodeId=8076859385e6, content=审稿速度:10.0 经验分享：我的还惨。投稿6个月整，才开始外审。外审又一个月，完了就拒绝了。看审稿意见基本是肯定的，应该是个大修。之后appeal了一下。编辑部说除非审稿意见是错误的，没有机会大修，就完事了。整体看审稿人的水平连plant physiol审稿人水平不如。所以很赞同这就是个**期刊。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de05414115, createdName=ms313574960747337, createdTime=Mon Apr 13 11:25:31 CST 2020, time=2020-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236847, encodeId=28dd123684e8c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：免疫;肿瘤;生物信息 经验分享：第14天被拒。整体速度感觉偏慢吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cac51677430, createdName=马疾香幽, createdTime=Sat Aug 06 00:55:47 CST 2022, time=2022-08-06, status=1, ipAttribution=)]

2020-09-09 你好，阿蒙

投SCIENCE TRANSLATIONAL MEDICINE被拒，建议转投此杂志，不知机会大不大

497 12

展开12条回复

[GetPortalCommentsPageByObjectIdResponse(id=883760, encodeId=5c5c883e6091, content= 投SCIENCE TRANSLATIONAL MEDICINE被拒，建议转投此杂志，不知机会大不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=497, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211006/298c300ad56d42b6a130908b27e6c26d/fc5b8fd50ac144f3973fdc4b334d8e25.jpg, createdBy=2bb42569605, createdName=你好，阿蒙, createdTime=Wed Sep 09 01:21:16 CST 2020, time=2020-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861823, encodeId=7f2786182372, content=审稿速度:4.0 经验分享：20200127 投稿 20200327 第一轮修改，三个审稿人（两个小修，一个大修） 20200505 第一轮修改，三个审稿人（两个同意接收，一个小修） 20200528 accept-technical hold 20200602 付版面费 4500 usd 20200612 accepted 希望对投稿的人有所帮助！！！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=590, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdbe5414035, createdName=ms3036779279854874, createdTime=Sat Jun 13 11:06:00 CST 2020, time=2020-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861406, encodeId=fb7f86140618, content=审稿速度:1.0 经验分享：大佬们的游戏而已，注定没法和pnas和子刊比 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=513, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e295414102, createdName=ms4512939187244456, createdTime=Thu Jun 04 09:47:58 CST 2020, time=2020-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860949, encodeId=41128609490c, content=审稿速度:1.0 经验分享：2019.05.24 transferred , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=465, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a595414065, createdName=ms6437770273944149, createdTime=Mon May 25 10:23:32 CST 2020, time=2020-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887481, encodeId=c72288e481a8, content=审稿速度:2.0 经验分享：课题被抢发到了JCI, 我们投立刻JCI被拒绝，19年9月投稿，12月接收，20年2月见刊。期间三个审稿人给了非常专业的问题，一一认真回答后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=328, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6811738319, createdName=James SUN, createdTime=Tue Sep 22 21:20:47 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125857, encodeId=992a212585e5b, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：等待煎熬中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9578600405, createdName=ms4000001399579030, createdTime=Fri Apr 14 10:26:25 CST 2023, time=2023-04-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=978565, encodeId=6b889e856566, content=偏重的研究方向：生物化学 经验分享：投稿到拒稿只用了4天，快乐！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1b35512140, createdName=大药, createdTime=Thu Jul 01 11:07:35 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601337, encodeId=ba1260133e43, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：这个杂志真不靠谱，投稿两个多月，换了几个编辑，最后没送审直接拒了。效率极低，耽误时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=423, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3ztLHSarrwfOxbw2WGK8AvWRfUlNGpox5ZAd4d306Fyt8IJ74jVsx5AFKXzgmazgF44vyNm25iaF8A/0, createdBy=2e152100215, createdName=jurryz, createdTime=Thu Jun 04 10:45:49 CST 2020, time=2020-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859385, encodeId=8076859385e6, content=审稿速度:10.0 经验分享：我的还惨。投稿6个月整，才开始外审。外审又一个月，完了就拒绝了。看审稿意见基本是肯定的，应该是个大修。之后appeal了一下。编辑部说除非审稿意见是错误的，没有机会大修，就完事了。整体看审稿人的水平连plant physiol审稿人水平不如。所以很赞同这就是个**期刊。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de05414115, createdName=ms313574960747337, createdTime=Mon Apr 13 11:25:31 CST 2020, time=2020-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236847, encodeId=28dd123684e8c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：免疫;肿瘤;生物信息 经验分享：第14天被拒。整体速度感觉偏慢吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cac51677430, createdName=马疾香幽, createdTime=Sat Aug 06 00:55:47 CST 2022, time=2022-08-06, status=1, ipAttribution=)]

2020-06-13 ms3036779279854874

审稿速度:4.0
经验分享：20200127 投稿
20200327 第一轮修改，三个审稿人（两个小修，一个大修）
20200505 第一轮修改，三个审稿人（两个同意接收，一个小修）
20200528 accept-technical hold
20200602 付版面费 4500 usd
20200612 accepted
希望对投稿的人有所帮助！！！

590 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=883760, encodeId=5c5c883e6091, content= 投SCIENCE TRANSLATIONAL MEDICINE被拒，建议转投此杂志，不知机会大不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=497, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211006/298c300ad56d42b6a130908b27e6c26d/fc5b8fd50ac144f3973fdc4b334d8e25.jpg, createdBy=2bb42569605, createdName=你好，阿蒙, createdTime=Wed Sep 09 01:21:16 CST 2020, time=2020-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861823, encodeId=7f2786182372, content=审稿速度:4.0 经验分享：20200127 投稿 20200327 第一轮修改，三个审稿人（两个小修，一个大修） 20200505 第一轮修改，三个审稿人（两个同意接收，一个小修） 20200528 accept-technical hold 20200602 付版面费 4500 usd 20200612 accepted 希望对投稿的人有所帮助！！！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=590, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdbe5414035, createdName=ms3036779279854874, createdTime=Sat Jun 13 11:06:00 CST 2020, time=2020-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861406, encodeId=fb7f86140618, content=审稿速度:1.0 经验分享：大佬们的游戏而已，注定没法和pnas和子刊比 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=513, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e295414102, createdName=ms4512939187244456, createdTime=Thu Jun 04 09:47:58 CST 2020, time=2020-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860949, encodeId=41128609490c, content=审稿速度:1.0 经验分享：2019.05.24 transferred , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=465, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a595414065, createdName=ms6437770273944149, createdTime=Mon May 25 10:23:32 CST 2020, time=2020-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887481, encodeId=c72288e481a8, content=审稿速度:2.0 经验分享：课题被抢发到了JCI, 我们投立刻JCI被拒绝，19年9月投稿，12月接收，20年2月见刊。期间三个审稿人给了非常专业的问题，一一认真回答后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=328, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6811738319, createdName=James SUN, createdTime=Tue Sep 22 21:20:47 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125857, encodeId=992a212585e5b, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：等待煎熬中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9578600405, createdName=ms4000001399579030, createdTime=Fri Apr 14 10:26:25 CST 2023, time=2023-04-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=978565, encodeId=6b889e856566, content=偏重的研究方向：生物化学 经验分享：投稿到拒稿只用了4天，快乐！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1b35512140, createdName=大药, createdTime=Thu Jul 01 11:07:35 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601337, encodeId=ba1260133e43, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：这个杂志真不靠谱，投稿两个多月，换了几个编辑，最后没送审直接拒了。效率极低，耽误时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=423, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3ztLHSarrwfOxbw2WGK8AvWRfUlNGpox5ZAd4d306Fyt8IJ74jVsx5AFKXzgmazgF44vyNm25iaF8A/0, createdBy=2e152100215, createdName=jurryz, createdTime=Thu Jun 04 10:45:49 CST 2020, time=2020-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859385, encodeId=8076859385e6, content=审稿速度:10.0 经验分享：我的还惨。投稿6个月整，才开始外审。外审又一个月，完了就拒绝了。看审稿意见基本是肯定的，应该是个大修。之后appeal了一下。编辑部说除非审稿意见是错误的，没有机会大修，就完事了。整体看审稿人的水平连plant physiol审稿人水平不如。所以很赞同这就是个**期刊。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de05414115, createdName=ms313574960747337, createdTime=Mon Apr 13 11:25:31 CST 2020, time=2020-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236847, encodeId=28dd123684e8c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：免疫;肿瘤;生物信息 经验分享：第14天被拒。整体速度感觉偏慢吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cac51677430, createdName=马疾香幽, createdTime=Sat Aug 06 00:55:47 CST 2022, time=2022-08-06, status=1, ipAttribution=)]

2020-06-04 ms4512939187244456

审稿速度:1.0
经验分享：大佬们的游戏而已，注定没法和pnas和子刊比

513 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=883760, encodeId=5c5c883e6091, content= 投SCIENCE TRANSLATIONAL MEDICINE被拒，建议转投此杂志，不知机会大不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=497, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211006/298c300ad56d42b6a130908b27e6c26d/fc5b8fd50ac144f3973fdc4b334d8e25.jpg, createdBy=2bb42569605, createdName=你好，阿蒙, createdTime=Wed Sep 09 01:21:16 CST 2020, time=2020-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861823, encodeId=7f2786182372, content=审稿速度:4.0 经验分享：20200127 投稿 20200327 第一轮修改，三个审稿人（两个小修，一个大修） 20200505 第一轮修改，三个审稿人（两个同意接收，一个小修） 20200528 accept-technical hold 20200602 付版面费 4500 usd 20200612 accepted 希望对投稿的人有所帮助！！！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=590, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdbe5414035, createdName=ms3036779279854874, createdTime=Sat Jun 13 11:06:00 CST 2020, time=2020-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861406, encodeId=fb7f86140618, content=审稿速度:1.0 经验分享：大佬们的游戏而已，注定没法和pnas和子刊比 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=513, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e295414102, createdName=ms4512939187244456, createdTime=Thu Jun 04 09:47:58 CST 2020, time=2020-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860949, encodeId=41128609490c, content=审稿速度:1.0 经验分享：2019.05.24 transferred , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=465, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a595414065, createdName=ms6437770273944149, createdTime=Mon May 25 10:23:32 CST 2020, time=2020-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887481, encodeId=c72288e481a8, content=审稿速度:2.0 经验分享：课题被抢发到了JCI, 我们投立刻JCI被拒绝，19年9月投稿，12月接收，20年2月见刊。期间三个审稿人给了非常专业的问题，一一认真回答后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=328, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6811738319, createdName=James SUN, createdTime=Tue Sep 22 21:20:47 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125857, encodeId=992a212585e5b, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：等待煎熬中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9578600405, createdName=ms4000001399579030, createdTime=Fri Apr 14 10:26:25 CST 2023, time=2023-04-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=978565, encodeId=6b889e856566, content=偏重的研究方向：生物化学 经验分享：投稿到拒稿只用了4天，快乐！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1b35512140, createdName=大药, createdTime=Thu Jul 01 11:07:35 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601337, encodeId=ba1260133e43, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：这个杂志真不靠谱，投稿两个多月，换了几个编辑，最后没送审直接拒了。效率极低，耽误时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=423, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3ztLHSarrwfOxbw2WGK8AvWRfUlNGpox5ZAd4d306Fyt8IJ74jVsx5AFKXzgmazgF44vyNm25iaF8A/0, createdBy=2e152100215, createdName=jurryz, createdTime=Thu Jun 04 10:45:49 CST 2020, time=2020-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859385, encodeId=8076859385e6, content=审稿速度:10.0 经验分享：我的还惨。投稿6个月整，才开始外审。外审又一个月，完了就拒绝了。看审稿意见基本是肯定的，应该是个大修。之后appeal了一下。编辑部说除非审稿意见是错误的，没有机会大修，就完事了。整体看审稿人的水平连plant physiol审稿人水平不如。所以很赞同这就是个**期刊。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de05414115, createdName=ms313574960747337, createdTime=Mon Apr 13 11:25:31 CST 2020, time=2020-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236847, encodeId=28dd123684e8c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：免疫;肿瘤;生物信息 经验分享：第14天被拒。整体速度感觉偏慢吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cac51677430, createdName=马疾香幽, createdTime=Sat Aug 06 00:55:47 CST 2022, time=2022-08-06, status=1, ipAttribution=)]

2020-05-25 ms6437770273944149

审稿速度:1.0
经验分享：2019.05.24 transferred

465 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=883760, encodeId=5c5c883e6091, content= 投SCIENCE TRANSLATIONAL MEDICINE被拒，建议转投此杂志，不知机会大不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=497, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211006/298c300ad56d42b6a130908b27e6c26d/fc5b8fd50ac144f3973fdc4b334d8e25.jpg, createdBy=2bb42569605, createdName=你好，阿蒙, createdTime=Wed Sep 09 01:21:16 CST 2020, time=2020-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861823, encodeId=7f2786182372, content=审稿速度:4.0 经验分享：20200127 投稿 20200327 第一轮修改，三个审稿人（两个小修，一个大修） 20200505 第一轮修改，三个审稿人（两个同意接收，一个小修） 20200528 accept-technical hold 20200602 付版面费 4500 usd 20200612 accepted 希望对投稿的人有所帮助！！！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=590, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdbe5414035, createdName=ms3036779279854874, createdTime=Sat Jun 13 11:06:00 CST 2020, time=2020-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861406, encodeId=fb7f86140618, content=审稿速度:1.0 经验分享：大佬们的游戏而已，注定没法和pnas和子刊比 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=513, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e295414102, createdName=ms4512939187244456, createdTime=Thu Jun 04 09:47:58 CST 2020, time=2020-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860949, encodeId=41128609490c, content=审稿速度:1.0 经验分享：2019.05.24 transferred , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=465, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a595414065, createdName=ms6437770273944149, createdTime=Mon May 25 10:23:32 CST 2020, time=2020-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887481, encodeId=c72288e481a8, content=审稿速度:2.0 经验分享：课题被抢发到了JCI, 我们投立刻JCI被拒绝，19年9月投稿，12月接收，20年2月见刊。期间三个审稿人给了非常专业的问题，一一认真回答后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=328, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6811738319, createdName=James SUN, createdTime=Tue Sep 22 21:20:47 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125857, encodeId=992a212585e5b, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：等待煎熬中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9578600405, createdName=ms4000001399579030, createdTime=Fri Apr 14 10:26:25 CST 2023, time=2023-04-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=978565, encodeId=6b889e856566, content=偏重的研究方向：生物化学 经验分享：投稿到拒稿只用了4天，快乐！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1b35512140, createdName=大药, createdTime=Thu Jul 01 11:07:35 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601337, encodeId=ba1260133e43, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：这个杂志真不靠谱，投稿两个多月，换了几个编辑，最后没送审直接拒了。效率极低，耽误时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=423, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3ztLHSarrwfOxbw2WGK8AvWRfUlNGpox5ZAd4d306Fyt8IJ74jVsx5AFKXzgmazgF44vyNm25iaF8A/0, createdBy=2e152100215, createdName=jurryz, createdTime=Thu Jun 04 10:45:49 CST 2020, time=2020-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859385, encodeId=8076859385e6, content=审稿速度:10.0 经验分享：我的还惨。投稿6个月整，才开始外审。外审又一个月，完了就拒绝了。看审稿意见基本是肯定的，应该是个大修。之后appeal了一下。编辑部说除非审稿意见是错误的，没有机会大修，就完事了。整体看审稿人的水平连plant physiol审稿人水平不如。所以很赞同这就是个**期刊。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de05414115, createdName=ms313574960747337, createdTime=Mon Apr 13 11:25:31 CST 2020, time=2020-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236847, encodeId=28dd123684e8c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：免疫;肿瘤;生物信息 经验分享：第14天被拒。整体速度感觉偏慢吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cac51677430, createdName=马疾香幽, createdTime=Sat Aug 06 00:55:47 CST 2022, time=2022-08-06, status=1, ipAttribution=)]

2020-09-22 James SUN

审稿速度:2.0
经验分享：课题被抢发到了JCI, 我们投立刻JCI被拒绝，19年9月投稿，12月接收，20年2月见刊。期间三个审稿人给了非常专业的问题，一一认真回答后接收。

328 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=883760, encodeId=5c5c883e6091, content= 投SCIENCE TRANSLATIONAL MEDICINE被拒，建议转投此杂志，不知机会大不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=497, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211006/298c300ad56d42b6a130908b27e6c26d/fc5b8fd50ac144f3973fdc4b334d8e25.jpg, createdBy=2bb42569605, createdName=你好，阿蒙, createdTime=Wed Sep 09 01:21:16 CST 2020, time=2020-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861823, encodeId=7f2786182372, content=审稿速度:4.0 经验分享：20200127 投稿 20200327 第一轮修改，三个审稿人（两个小修，一个大修） 20200505 第一轮修改，三个审稿人（两个同意接收，一个小修） 20200528 accept-technical hold 20200602 付版面费 4500 usd 20200612 accepted 希望对投稿的人有所帮助！！！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=590, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdbe5414035, createdName=ms3036779279854874, createdTime=Sat Jun 13 11:06:00 CST 2020, time=2020-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861406, encodeId=fb7f86140618, content=审稿速度:1.0 经验分享：大佬们的游戏而已，注定没法和pnas和子刊比 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=513, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e295414102, createdName=ms4512939187244456, createdTime=Thu Jun 04 09:47:58 CST 2020, time=2020-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860949, encodeId=41128609490c, content=审稿速度:1.0 经验分享：2019.05.24 transferred , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=465, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a595414065, createdName=ms6437770273944149, createdTime=Mon May 25 10:23:32 CST 2020, time=2020-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887481, encodeId=c72288e481a8, content=审稿速度:2.0 经验分享：课题被抢发到了JCI, 我们投立刻JCI被拒绝，19年9月投稿，12月接收，20年2月见刊。期间三个审稿人给了非常专业的问题，一一认真回答后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=328, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6811738319, createdName=James SUN, createdTime=Tue Sep 22 21:20:47 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125857, encodeId=992a212585e5b, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：等待煎熬中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9578600405, createdName=ms4000001399579030, createdTime=Fri Apr 14 10:26:25 CST 2023, time=2023-04-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=978565, encodeId=6b889e856566, content=偏重的研究方向：生物化学 经验分享：投稿到拒稿只用了4天，快乐！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1b35512140, createdName=大药, createdTime=Thu Jul 01 11:07:35 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601337, encodeId=ba1260133e43, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：这个杂志真不靠谱，投稿两个多月，换了几个编辑，最后没送审直接拒了。效率极低，耽误时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=423, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3ztLHSarrwfOxbw2WGK8AvWRfUlNGpox5ZAd4d306Fyt8IJ74jVsx5AFKXzgmazgF44vyNm25iaF8A/0, createdBy=2e152100215, createdName=jurryz, createdTime=Thu Jun 04 10:45:49 CST 2020, time=2020-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859385, encodeId=8076859385e6, content=审稿速度:10.0 经验分享：我的还惨。投稿6个月整，才开始外审。外审又一个月，完了就拒绝了。看审稿意见基本是肯定的，应该是个大修。之后appeal了一下。编辑部说除非审稿意见是错误的，没有机会大修，就完事了。整体看审稿人的水平连plant physiol审稿人水平不如。所以很赞同这就是个**期刊。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de05414115, createdName=ms313574960747337, createdTime=Mon Apr 13 11:25:31 CST 2020, time=2020-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236847, encodeId=28dd123684e8c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：免疫;肿瘤;生物信息 经验分享：第14天被拒。整体速度感觉偏慢吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cac51677430, createdName=马疾香幽, createdTime=Sat Aug 06 00:55:47 CST 2022, time=2022-08-06, status=1, ipAttribution=)]

2023-04-14 ms4000001399579030 来自山东省

审稿速度:12.0 | 投稿命中率:25.0
经验分享：等待煎熬中

126 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=883760, encodeId=5c5c883e6091, content= 投SCIENCE TRANSLATIONAL MEDICINE被拒，建议转投此杂志，不知机会大不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=497, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211006/298c300ad56d42b6a130908b27e6c26d/fc5b8fd50ac144f3973fdc4b334d8e25.jpg, createdBy=2bb42569605, createdName=你好，阿蒙, createdTime=Wed Sep 09 01:21:16 CST 2020, time=2020-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861823, encodeId=7f2786182372, content=审稿速度:4.0 经验分享：20200127 投稿 20200327 第一轮修改，三个审稿人（两个小修，一个大修） 20200505 第一轮修改，三个审稿人（两个同意接收，一个小修） 20200528 accept-technical hold 20200602 付版面费 4500 usd 20200612 accepted 希望对投稿的人有所帮助！！！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=590, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdbe5414035, createdName=ms3036779279854874, createdTime=Sat Jun 13 11:06:00 CST 2020, time=2020-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861406, encodeId=fb7f86140618, content=审稿速度:1.0 经验分享：大佬们的游戏而已，注定没法和pnas和子刊比 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=513, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e295414102, createdName=ms4512939187244456, createdTime=Thu Jun 04 09:47:58 CST 2020, time=2020-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860949, encodeId=41128609490c, content=审稿速度:1.0 经验分享：2019.05.24 transferred , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=465, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a595414065, createdName=ms6437770273944149, createdTime=Mon May 25 10:23:32 CST 2020, time=2020-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887481, encodeId=c72288e481a8, content=审稿速度:2.0 经验分享：课题被抢发到了JCI, 我们投立刻JCI被拒绝，19年9月投稿，12月接收，20年2月见刊。期间三个审稿人给了非常专业的问题，一一认真回答后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=328, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6811738319, createdName=James SUN, createdTime=Tue Sep 22 21:20:47 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125857, encodeId=992a212585e5b, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：等待煎熬中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9578600405, createdName=ms4000001399579030, createdTime=Fri Apr 14 10:26:25 CST 2023, time=2023-04-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=978565, encodeId=6b889e856566, content=偏重的研究方向：生物化学 经验分享：投稿到拒稿只用了4天，快乐！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1b35512140, createdName=大药, createdTime=Thu Jul 01 11:07:35 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601337, encodeId=ba1260133e43, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：这个杂志真不靠谱，投稿两个多月，换了几个编辑，最后没送审直接拒了。效率极低，耽误时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=423, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3ztLHSarrwfOxbw2WGK8AvWRfUlNGpox5ZAd4d306Fyt8IJ74jVsx5AFKXzgmazgF44vyNm25iaF8A/0, createdBy=2e152100215, createdName=jurryz, createdTime=Thu Jun 04 10:45:49 CST 2020, time=2020-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859385, encodeId=8076859385e6, content=审稿速度:10.0 经验分享：我的还惨。投稿6个月整，才开始外审。外审又一个月，完了就拒绝了。看审稿意见基本是肯定的，应该是个大修。之后appeal了一下。编辑部说除非审稿意见是错误的，没有机会大修，就完事了。整体看审稿人的水平连plant physiol审稿人水平不如。所以很赞同这就是个**期刊。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de05414115, createdName=ms313574960747337, createdTime=Mon Apr 13 11:25:31 CST 2020, time=2020-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236847, encodeId=28dd123684e8c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：免疫;肿瘤;生物信息 经验分享：第14天被拒。整体速度感觉偏慢吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cac51677430, createdName=马疾香幽, createdTime=Sat Aug 06 00:55:47 CST 2022, time=2022-08-06, status=1, ipAttribution=)]

2021-07-01 大药

偏重的研究方向：生物化学
经验分享：投稿到拒稿只用了4天，快乐！

324 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=883760, encodeId=5c5c883e6091, content= 投SCIENCE TRANSLATIONAL MEDICINE被拒，建议转投此杂志，不知机会大不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=497, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211006/298c300ad56d42b6a130908b27e6c26d/fc5b8fd50ac144f3973fdc4b334d8e25.jpg, createdBy=2bb42569605, createdName=你好，阿蒙, createdTime=Wed Sep 09 01:21:16 CST 2020, time=2020-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861823, encodeId=7f2786182372, content=审稿速度:4.0 经验分享：20200127 投稿 20200327 第一轮修改，三个审稿人（两个小修，一个大修） 20200505 第一轮修改，三个审稿人（两个同意接收，一个小修） 20200528 accept-technical hold 20200602 付版面费 4500 usd 20200612 accepted 希望对投稿的人有所帮助！！！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=590, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdbe5414035, createdName=ms3036779279854874, createdTime=Sat Jun 13 11:06:00 CST 2020, time=2020-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861406, encodeId=fb7f86140618, content=审稿速度:1.0 经验分享：大佬们的游戏而已，注定没法和pnas和子刊比 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=513, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e295414102, createdName=ms4512939187244456, createdTime=Thu Jun 04 09:47:58 CST 2020, time=2020-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860949, encodeId=41128609490c, content=审稿速度:1.0 经验分享：2019.05.24 transferred , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=465, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a595414065, createdName=ms6437770273944149, createdTime=Mon May 25 10:23:32 CST 2020, time=2020-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887481, encodeId=c72288e481a8, content=审稿速度:2.0 经验分享：课题被抢发到了JCI, 我们投立刻JCI被拒绝，19年9月投稿，12月接收，20年2月见刊。期间三个审稿人给了非常专业的问题，一一认真回答后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=328, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6811738319, createdName=James SUN, createdTime=Tue Sep 22 21:20:47 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125857, encodeId=992a212585e5b, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：等待煎熬中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9578600405, createdName=ms4000001399579030, createdTime=Fri Apr 14 10:26:25 CST 2023, time=2023-04-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=978565, encodeId=6b889e856566, content=偏重的研究方向：生物化学 经验分享：投稿到拒稿只用了4天，快乐！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1b35512140, createdName=大药, createdTime=Thu Jul 01 11:07:35 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601337, encodeId=ba1260133e43, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：这个杂志真不靠谱，投稿两个多月，换了几个编辑，最后没送审直接拒了。效率极低，耽误时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=423, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3ztLHSarrwfOxbw2WGK8AvWRfUlNGpox5ZAd4d306Fyt8IJ74jVsx5AFKXzgmazgF44vyNm25iaF8A/0, createdBy=2e152100215, createdName=jurryz, createdTime=Thu Jun 04 10:45:49 CST 2020, time=2020-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859385, encodeId=8076859385e6, content=审稿速度:10.0 经验分享：我的还惨。投稿6个月整，才开始外审。外审又一个月，完了就拒绝了。看审稿意见基本是肯定的，应该是个大修。之后appeal了一下。编辑部说除非审稿意见是错误的，没有机会大修，就完事了。整体看审稿人的水平连plant physiol审稿人水平不如。所以很赞同这就是个**期刊。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de05414115, createdName=ms313574960747337, createdTime=Mon Apr 13 11:25:31 CST 2020, time=2020-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236847, encodeId=28dd123684e8c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：免疫;肿瘤;生物信息 经验分享：第14天被拒。整体速度感觉偏慢吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cac51677430, createdName=马疾香幽, createdTime=Sat Aug 06 00:55:47 CST 2022, time=2022-08-06, status=1, ipAttribution=)]

2020-06-04 jurryz

审稿速度:6.0 | 投稿命中率:25.0
经验分享：这个杂志真不靠谱，投稿两个多月，换了几个编辑，最后没送审直接拒了。效率极低，耽误时间。

423 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=883760, encodeId=5c5c883e6091, content= 投SCIENCE TRANSLATIONAL MEDICINE被拒，建议转投此杂志，不知机会大不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=497, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211006/298c300ad56d42b6a130908b27e6c26d/fc5b8fd50ac144f3973fdc4b334d8e25.jpg, createdBy=2bb42569605, createdName=你好，阿蒙, createdTime=Wed Sep 09 01:21:16 CST 2020, time=2020-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861823, encodeId=7f2786182372, content=审稿速度:4.0 经验分享：20200127 投稿 20200327 第一轮修改，三个审稿人（两个小修，一个大修） 20200505 第一轮修改，三个审稿人（两个同意接收，一个小修） 20200528 accept-technical hold 20200602 付版面费 4500 usd 20200612 accepted 希望对投稿的人有所帮助！！！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=590, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdbe5414035, createdName=ms3036779279854874, createdTime=Sat Jun 13 11:06:00 CST 2020, time=2020-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861406, encodeId=fb7f86140618, content=审稿速度:1.0 经验分享：大佬们的游戏而已，注定没法和pnas和子刊比 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=513, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e295414102, createdName=ms4512939187244456, createdTime=Thu Jun 04 09:47:58 CST 2020, time=2020-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860949, encodeId=41128609490c, content=审稿速度:1.0 经验分享：2019.05.24 transferred , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=465, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a595414065, createdName=ms6437770273944149, createdTime=Mon May 25 10:23:32 CST 2020, time=2020-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887481, encodeId=c72288e481a8, content=审稿速度:2.0 经验分享：课题被抢发到了JCI, 我们投立刻JCI被拒绝，19年9月投稿，12月接收，20年2月见刊。期间三个审稿人给了非常专业的问题，一一认真回答后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=328, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6811738319, createdName=James SUN, createdTime=Tue Sep 22 21:20:47 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125857, encodeId=992a212585e5b, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：等待煎熬中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9578600405, createdName=ms4000001399579030, createdTime=Fri Apr 14 10:26:25 CST 2023, time=2023-04-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=978565, encodeId=6b889e856566, content=偏重的研究方向：生物化学 经验分享：投稿到拒稿只用了4天，快乐！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1b35512140, createdName=大药, createdTime=Thu Jul 01 11:07:35 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601337, encodeId=ba1260133e43, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：这个杂志真不靠谱，投稿两个多月，换了几个编辑，最后没送审直接拒了。效率极低，耽误时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=423, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3ztLHSarrwfOxbw2WGK8AvWRfUlNGpox5ZAd4d306Fyt8IJ74jVsx5AFKXzgmazgF44vyNm25iaF8A/0, createdBy=2e152100215, createdName=jurryz, createdTime=Thu Jun 04 10:45:49 CST 2020, time=2020-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859385, encodeId=8076859385e6, content=审稿速度:10.0 经验分享：我的还惨。投稿6个月整，才开始外审。外审又一个月，完了就拒绝了。看审稿意见基本是肯定的，应该是个大修。之后appeal了一下。编辑部说除非审稿意见是错误的，没有机会大修，就完事了。整体看审稿人的水平连plant physiol审稿人水平不如。所以很赞同这就是个**期刊。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de05414115, createdName=ms313574960747337, createdTime=Mon Apr 13 11:25:31 CST 2020, time=2020-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236847, encodeId=28dd123684e8c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：免疫;肿瘤;生物信息 经验分享：第14天被拒。整体速度感觉偏慢吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cac51677430, createdName=马疾香幽, createdTime=Sat Aug 06 00:55:47 CST 2022, time=2022-08-06, status=1, ipAttribution=)]

2020-04-13 ms313574960747337

审稿速度:10.0
经验分享：我的还惨。投稿6个月整，才开始外审。外审又一个月，完了就拒绝了。看审稿意见基本是肯定的，应该是个大修。之后appeal了一下。编辑部说除非审稿意见是错误的，没有机会大修，就完事了。整体看审稿人的水平连plant physiol审稿人水平不如。所以很赞同这就是个**期刊。

130 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=883760, encodeId=5c5c883e6091, content= 投SCIENCE TRANSLATIONAL MEDICINE被拒，建议转投此杂志，不知机会大不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=497, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211006/298c300ad56d42b6a130908b27e6c26d/fc5b8fd50ac144f3973fdc4b334d8e25.jpg, createdBy=2bb42569605, createdName=你好，阿蒙, createdTime=Wed Sep 09 01:21:16 CST 2020, time=2020-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861823, encodeId=7f2786182372, content=审稿速度:4.0 经验分享：20200127 投稿 20200327 第一轮修改，三个审稿人（两个小修，一个大修） 20200505 第一轮修改，三个审稿人（两个同意接收，一个小修） 20200528 accept-technical hold 20200602 付版面费 4500 usd 20200612 accepted 希望对投稿的人有所帮助！！！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=590, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdbe5414035, createdName=ms3036779279854874, createdTime=Sat Jun 13 11:06:00 CST 2020, time=2020-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861406, encodeId=fb7f86140618, content=审稿速度:1.0 经验分享：大佬们的游戏而已，注定没法和pnas和子刊比 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=513, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e295414102, createdName=ms4512939187244456, createdTime=Thu Jun 04 09:47:58 CST 2020, time=2020-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860949, encodeId=41128609490c, content=审稿速度:1.0 经验分享：2019.05.24 transferred , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=465, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a595414065, createdName=ms6437770273944149, createdTime=Mon May 25 10:23:32 CST 2020, time=2020-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887481, encodeId=c72288e481a8, content=审稿速度:2.0 经验分享：课题被抢发到了JCI, 我们投立刻JCI被拒绝，19年9月投稿，12月接收，20年2月见刊。期间三个审稿人给了非常专业的问题，一一认真回答后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=328, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6811738319, createdName=James SUN, createdTime=Tue Sep 22 21:20:47 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125857, encodeId=992a212585e5b, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：等待煎熬中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9578600405, createdName=ms4000001399579030, createdTime=Fri Apr 14 10:26:25 CST 2023, time=2023-04-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=978565, encodeId=6b889e856566, content=偏重的研究方向：生物化学 经验分享：投稿到拒稿只用了4天，快乐！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1b35512140, createdName=大药, createdTime=Thu Jul 01 11:07:35 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601337, encodeId=ba1260133e43, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：这个杂志真不靠谱，投稿两个多月，换了几个编辑，最后没送审直接拒了。效率极低，耽误时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=423, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3ztLHSarrwfOxbw2WGK8AvWRfUlNGpox5ZAd4d306Fyt8IJ74jVsx5AFKXzgmazgF44vyNm25iaF8A/0, createdBy=2e152100215, createdName=jurryz, createdTime=Thu Jun 04 10:45:49 CST 2020, time=2020-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859385, encodeId=8076859385e6, content=审稿速度:10.0 经验分享：我的还惨。投稿6个月整，才开始外审。外审又一个月，完了就拒绝了。看审稿意见基本是肯定的，应该是个大修。之后appeal了一下。编辑部说除非审稿意见是错误的，没有机会大修，就完事了。整体看审稿人的水平连plant physiol审稿人水平不如。所以很赞同这就是个**期刊。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de05414115, createdName=ms313574960747337, createdTime=Mon Apr 13 11:25:31 CST 2020, time=2020-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236847, encodeId=28dd123684e8c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：免疫;肿瘤;生物信息 经验分享：第14天被拒。整体速度感觉偏慢吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cac51677430, createdName=马疾香幽, createdTime=Sat Aug 06 00:55:47 CST 2022, time=2022-08-06, status=1, ipAttribution=)]

2022-08-06 马疾香幽

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：免疫;肿瘤;生物信息
经验分享：第14天被拒。整体速度感觉偏慢吧。

203 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务